Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Matthias Preusser(Medical University of Vienna), Wolfgang Wick(German Cancer Research Center), Alice Bonneville-Levard(Centre Léon Bérard), Jaap C. Reijneveld(Amsterdam UMC Location University of Amsterdam), Michael Weller(University Hospital of Zurich), Martin Bendszus(Heidelberg University), Charlotte Bronnimann(Centre Hospitalier Universitaire de Bordeaux), Jacoline E. C. Bromberg(Erasmus MC), Julia Furtner(Medical University of Vienna), Petter Brandal(Oslo University Hospital), Christian Mawrin(University Hospital Magdeburg), Élodie Vauléon(Université Claude Bernard Lyon 1), Corneel Coens(European Organisation for Research and Treatment of Cancer), Thierry Gorlia(European Organisation for Research and Treatment of Cancer), Philipp Sievers(German Cancer Research Center), Véronique Lorgis(UniCancer Group), Christine Marosi, Josef Pichler(Johannes Kepler University of Linz), Sara Erridge(The University of Texas MD Anderson Cancer Center), François Ducray(Centre National pour la Recherche Scientifique et Technique (CNRST)), Carmen Balañá(Institut Català d'Oncologia), Giuseppe Lombardi(University of Pisa), Alison Cameron(University Hospitals Bristol NHS Foundation Trust), Felix Sahm(German Cancer Research Center), Jordi Bruna(Universitat Autònoma de Barcelona), Marc Sanson(Centre National de la Recherche Scientifique), Niklas Thon(LMU Klinikum), Émilie Le Rhun(University of Zurich), Juan Manuel Sepúlveda-Sánchez(Hospital Universitario 12 De Octubre), Maximilian J. Mair(Medical University of Vienna), Sarah Dumont(Institut Gustave Roussy), Riccardo Soffietti(Azienda Ospedaliero Universitaria San Giovanni Battista), Joanne Lewis(Freeman Hospital), Vassilis Golfinopoulos(Champalimaud Foundation), Lucy Brazil(St Thomas' Hospital), Paul M. Clément(Universitair Ziekenhuis Leuven), Florence Lefranc(Université Libre de Bruxelles), Antonio Silvani
Cited by 81
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k